Depression prevention requires identifying key risk contributors. Prior studies have identified several factors related to late-life depression but have seldom addressed factors jointly or in doseresponse fashion. This study aimed to examine a wide range of potential predisposing factors and to estimate individual and joint contributions to risk of late-life depression in women. A total of 21,728 women aged ≥65 years, without prior depression, in the Nurses' Health Study conducted in the United States were followed from 2000-2010. Demographic, social, lifestyle/behavioral and health variables were selected a priori from the literature or previous findings in this cohort.
Incident late-life depression (LLD) is defined as depression occurring for the first time typically after age 60 or 65, and is a common and life-impairing mental health problem in older people. LLD can be distinguished from early-life depression in both etiology and phenomology (1) . Even with appropriate treatment, residual symptoms and dysfunction are common, underscoring the priority for prevention. A critical step in developing a rational prevention strategy is to determine major contributors to disease. Although the exact etiology is not fully understood, prior evidence points to key factors as potentially highimpact in LLD risk (2, 3) , such as medical comorbidity burden and physical/functional limitations or disability. However, other potentially modifiable factors have been examined less comprehensively. In the literature in investigating LLD risk, potential limitations include: (1) risk factor information is often available once at baseline (4, 5) ; (2) association patterns (threshold/dose-response/plateau effects) are unclear due to lack of data (6) ; (3) since health and lifestyle behaviors are often correlated, studying one factor without adjustment for relevant confounders may bias results; and (4) although average daily alcohol intake has been examined in prospective studies (4, 7, 8) , the specific relation of heavy or binge drinking to LLD risk has been relatively understudied.
To address the above challenges, we conducted prospective analyses in the Nurses' Health Study (NHS), a well-characaterized cohort of women. We related potential risk factors to incident LLD, defined as onset among those aged ≥65 years, and aimed to investigate a comprehensive array of potential risk/protective factors simultaneously -with particular attention to potentially-modifiable factors. We applied the Institute of Medicine concept of selective prevention (addressing persons at heightened risk for a clinical outcome), by addressing demographic, social, lifestyle/behavioral and health/medical factors which may place older women at high risk for developing depression. With respect to health factors, we were specifically interested in addressing sleep issues because emerging evidence supports sleep difficulty as an independent risk factor for depression (9, 10) -rather than merely a manifestation of it.
METHODS The Nurses' Health Study
The NHS began in 1976 when 121,700 U.S. female nurses, aged 30-55 years, returned a mailed questionnaire regarding lifestyle and medical history. Participants have received questionnaires biennially since then, with >90% follow-up rate in each 2-year cycle.
Risk and protective factors
All of the potential risk/protective factors examined in this study were self-reported from NHS questionnaires. They were selected a priori from the literature or prior NHS findings (2, 3, 11) and were grouped into 4 categories:
1.
Demographic: Age (continuous, in years); education (registered nurse/bachelor/ advanced degree); and race/ethnicity (non-Hispanic whites/blacks/others).
2.
Social: Social network, measured by the simplified Berkman-Syme Social Network Index (incorporating information of marital status, number of close contacts, church attendance, and participation in community organizations) (quintiles; higher quintile representing higher level of social network)(12); low subjective social status (measured using a 10-point visual analog scale of subjective feeling about standing in U.S. society) (high/medium-high/mediumlow/low standing)(13); hours of regular caregiving to children/grandchildren and to disabled/ill relatives (no/some(1-20 hours/week)/a lot(>20 hours/week)).
3.
Lifestyle/behavioral: Body mass index (BMI, in kg/m 2 ) (<18. For each variable, the category with hypothesized lower/lowest risk was the referent. The category with most individuals was the referent if the category of putatively lower/lowest risk was uncertain. For the factors that did not have straightforward cutoffs, the cutoffs were determined by the distribution of response options, their plausible expected associations, and their conceptual degrees of intensity or severity. For caregiving intensity, because our data could not distinguish between people providing no care and those who did not have specific family members to be cared for, both groups jointly served as the referent.
Assessment and measures of depression
Depression information included self-reported depressive symptoms, regular use of antidepressants, and physician/clinician diagnosis. Symptoms were assessed using the Mental Health Index-5 (MHI-5) subscale of the SF-36 in 1992, 1996, and 2000, the Center for Epidemiologic Studies Depression-10 (CESD-10) in 2004 and the Geriatric Depression Scale-15 (GDS-15) in 2008, all of which have validated cutpoints for clinical depression (23) (24) (25) . Questions on antidepressant use and physician/clinician diagnosis of depression were assessed biennially since 1996 and 2000, respectively. Because 2000 was the earliest year in which we could classify women as ever having doctor-diagnosed depression, we designated this as the study baseline.
Because the NHS questionnaire was asked biennially, participants reported on their depressive symptoms, medications, or doctor diagnosis within each 2-year time window. We had no information on the number or duration of discrete depressive episodes within 2-year windows, so recurrent depression events could not be unambiguously determined; therefore, we only examined incidence in this study. The date of incident LLD onset was defined by the first occurrence of physician/clinician-diagnosed depression, regular antidepressant use, or severe depressive symptoms using published cutpoints during follow-up (24, 25) . This 'Boolean OR' definition was applied, as preliminary data from an ongoing validation study support its optimal sensitivity and specificity. For antidepressants, we included selective serotonin reuptake inhibitors but not tricyclic antidepressants (TCAs), as we found elsewhere that TCAs would be more likely to be prescribed for other indications (26) . Because we specifically aimed to examine the associations between sleep problems and depression risk, the item related to sleep in CESD-10 ("my sleep was restless") was removed for scoring. To be conservative, we did not alter the cutoff score of CESD-10 for probable depression after excluding the sleep item, so that a participant's CESD-10 score was not influenced by her sleep symptoms but by the severity of the remaining depressive symptoms. As expected, the observed LLD incidence was lower when using only 9 items compared to using 10 items (21.9 and 26.4 per 1000 person-years, respectively), although both estimates were in the range of LLD incidence estimates among women in prior studies that featured clinical evaluations of depression (27) (28) (29) .
Sample for analysis
After excluding women who died before 2000 or did not return the 2000 questionnaire (n=26,908), whose history of depression could not be determined (n=33,757), who had prior indication of depression assessed by MHI-5 score, physician/clinician diagnosis or antidepressant medication (n=13,610), who aged under 65 years (n=19,095), who did not provide information on all risk factors selected a priori (n=5,863), who stopped returning questionnaires after 2000 (n=562) or had no health examination during follow-up (so there is no opportunity for depression detection)(n=177), 21,728 women were included for analysis ( Figure 1 ). The institutional review board at Brigham and Women's Hospital approved the study protocol. behaviors, comorbidity, and physical/functional limitations). We carried forward risk/ protective factor information in the prior questionnaire cycle if missing during follow-up (6.4% of data). The collinearity diagnostics results suggested that the multicollinearity was not a major concern; the variance inflation factors of all variables included in the model were 1.01-2.60. The proportional hazards assumptions were not violated.
Statistical methods

Estimating depression incidence-Since
To scrutinize robustness of results, we conducted three sensitivity analyses: (1) excluding cases in the first 2 years of follow-up and adding a 2-year outcome lag to address potential reverse causation (e.g., incipient depression may lead to changes in sleep or physical activity), and further performing a 6-year lagged analysis for additional scrutiny of reverse causation; (2) applying alternative definitions of depression -either a stricter definition of clinical depression, utilized previously, based only on diagnosis or treatment (31) or a less strict definition of diagnosis, symptoms, or antidepressant use including TCAs; and (3) censoring person-years once participants failed to provide information on all exposures of interest anytime during follow-up.
Estimating contributions to total risk of late-life depression-To estimate the proportion of LLD attributable to different factors, we calculated population attributable fractions (PAF) and corresponding 95% CIs using methods detailed elsewhere (32) . We interpreted the PAF as the estimated percentage of new LLD cases occurring in this population that could have been prevented if all women had been in the low-risk group. We dichotomized each factor in PAF calculation for simplicity and increased statistical efficiency. We chose the binary cutoffs which may optimally reflect the most relevant contrasts and reasonable counterfactual referent in the older population. This dichotomization was also guided by the primary analysis results (Model 3, Table 2 ). The estimated PAF calculated for each risk factor was adjusted for other significant exposures in the primary analysis. Because physical/functional limitation was the most prevalent risk factor with the largest single PAF (see under Results), yet was more difficult to modify, we further performed PAF analyses stratified by this factor to investigate the contributions of different risk factors to LLD risk among those with and without physical/functional limitations.
Statistical analyses were conducted using SAS v. 9.3 (SAS Institute Inc., Cary, NC). All Pvalues were 2-sided (P < 0.05).
RESULTS
The distributions of baseline characteristics were shown in Table 1 . We documented 3,945 incident LLD cases during 10-year follow-up; the overall incidence was 21.9 per 1000 person-years, consistent with age-and gender-specific depression incidence observed previously (27, 28) . The following factors were significantly associated with higher LLD risk in age-adjusted models, listed here by category: social factors (lower social network; lower subjective social status; high caregiving burden to disabled/ill relatives), lifestyle/ behavioral factors (overweight/obesity; low aMed diet score; cigarette smoking; physical inactivity; heavy/binge drinking), and health/medical conditions (medical comorbidity; ≤6 or ≥9 hours/day of sleep; difficulty falling/staying asleep; bodily pain; physical/functional limitations); higher education level was associated with lower LLD risk ( Three sensitivity analyses showed similar results. (1) exposure-LLD associations remained largely unchanged when we imposed a 2-year lag between exposure assessment and each follow-up period (Supplemental Table 1 ). Notably, there was no significant inverse association between BMI and LLD risk in the lagged analysis, suggesting that the observed significance in primary analyses may be attributable to weight change as an early manifestation of depression. The positive association between difficulty sleeping and LLD risk remained significant both in the 2-and 6-year lagged analyses. 6-year lagged analysis showed that compared to women without any sleep difficulty, those with difficulty falling/ staying asleep most/all the time had a HR of 1.56 (95% CI: 1.15, 2.10; data not shown in table) . (2) When depression was alternatively defined by diagnosis or treatment, the estimated LLD incidence was 12.5 per 1,000 person-years, given lower case sensitivity of this definition. However, findings were mostly consistent with those from primary analyses. Exceptions were heavy/binge drinking, subjective social status, and smoking: point estimates were similar but no longer statistically significant, likely due to substantial reductions in category numbers in these already small groups (data not shown). When the definition of depression included TCAs use (adding additional 5% of cases), the findings were mostly consistent with those in the primary analyses, except the suggestive association between the lowest aMed diet score and LLD [HR(95% CI): 1.10 (0.99, 1.23)]. (3) Finally, the LLD incidence was identical in analyses with and without carrying-forward missing information on risk factors during follow-up. Effect estimates were highly similar using either approach (data not shown).
When relating risk factors to population impact from the prevention perspective, the factor with the largest PAF was physical/functional limitation (26.4%). Other factors with PAF values of ≥10% included: sleep difficulty some to all of the time, no/very little exercise, and moderate to very severe bodily pain, together accounted for 31.6% of cases. Considering all significant risk factors in this study, the total PAF was 55.5% (95% CI: 42.1%, 66.5%). When grouping related factors, the estimated PAFs due to health problems, unfavorable lifestyle behaviors, and social factors were 46.1%, 12.5%, and 6.4%, respectively. After stratifying by the presence of physical/functional limitations, problematic sleep, low exercise, and bodily pain remained the top risk factors, by PAF, in both subgroups; however, they jointly accounted for almost double the LLD cases among women with limitations compared to those without limitations. Heavy/binge drinking accounted for 1.7% of new cases overall but explained 4.3% among those without limitations (Table 4) . Overall, behavioral factors appeared to contribute approximately equally to LLD among women with and without physical/functional limitations; however, health factors had much larger contributions to risk among women with limitations.
DISCUSSION
To out knowledge, this is the largest study to date that comprehensively and simultaneously examined a wide array of exposures for LLD in women. In this prospective cohort of U.S. women, we observed that poor physical health, unhealthy behaviors and social stressors were significantly associated with increased LLD risk in a dose-response fashion. Sleep difficulty was significantly associated with subsequent LLD risk, and heavy/binge drinking may be an important risk factor for LLD in women. Furthermore, the PAF analysis findings have public health implications. First, physical/functional limitation was the top risk factor in explaining new LLD cases. Our results point to the importance of early interventions to prevent onset of such limitations with respect to depression risk. Second, because we investigated risk factors separately among women with versus without physical/functional limitations, our data can preliminarily inform how depression prevention strategies may need to differ between these groups and also highlight the need for additional research in this area. In addition, the risk factors examined in this study combined to play a larger role, in PAF, among women with physical/functional limitations compared to those without, suggesting that other risk factors remain to be elucidated among women without limitations. Finally, our data suggest that one-third of all incident LLD may be explained by sleep, exercise and pain; optimizing primary care approaches to intervene early or to prevent sleep problems and pain before reaching clinical manifestations and to promote exercise appears a logical "next-step" for LLD prevention.
In placing these findings in the context of the existing literature, several points can be highlighted. First, several of our key findings (e.g., regarding physical/functional limitation, medical comorbidity and sleep) were consistent with prior reports (2, 3, 9, 33, 34) . Similarly in keeping with prior work (4, 5, 8, (35) (36) (37) (38) , we observed that physical inactivity and smoking were independently related to LLD risk. Second, in an expansion upon the existing literature, we were able to demonstrate dosage effects for most exposures; prior studies typically lacked adequate sample sizes or exposure detail to do so (4, 8, 35, 37, 38) . Third, our findings regarding caregiving reinforced the importance of distinguishing types of caregiving activities: in our study, high volume of caregiving to disabled/ill persons was related to higher LLD risk, in line with a cross-sectional study (39) , while decreased LLD risk was found for high volume of caregiving to children/grandchildren. Indeed, Tsai et al. reported that interactions with children/grandchildren may benefit older adults' psychological well-being (40) . Fourth, although significant positive associations have been reported elsewhere (33, 38, 41) , significant associations between low aMed diet and short sleep duration and LLD risk were only observed in age-but not multivariable-adjusted analyses in our study. These underscore the importance of confounder adjustment when examining such associations (e.g., in our study, the estimated risk associated with sleeping ≤6 hours/day was confounded by having difficulty falling/staying asleep). Furthermore, opposite association directions between overweight/obesity and LLD risk were observed in age-and multivariable-adjusted models; yet, overweight/obesity was not significantly associated with LLD risk in 2-year lagged analyses, highlighting the complex relationships between BMI and depression. Finally, our results raised awareness of relatively understudied factors: e.g., heavy/binge drinking was a risk factor for LLD, particularly among women without physical/functional limitations; further work is warranted to confirm these findings.
The strengths of the study include prospective design, large sample size, lengthy follow-up, a comprehensive set of risk factors, and repeated assessments of health and behavioral variables. An advantage of the current study, compared to prior investigations with smaller sample sizes, was the ability to consider a broad a range of predictors simultaneously and to use finer categorizations of exposures to explore intensity/dose-response relations. The use of time-varying data also allowed better handling of potential confounding. Finally, the large number of incident cases facilitated addressing contributions to total risk, including within subgroups.
Limitations also warrant discussion. First, outcome misclassification is anticipated when self-reported physican/clinician diagnosis, antidepressant use, or depressive symptoms were used to define depression. Clinicians may incorrectly consider some depressive symptoms as part of normal aging, leading to under-diagnosis of depression. However, the LLD incidence in our study is consistent with estimates from prior studies featuring clinical evaluations to define depression (27, 28) . Furthermore, prior NHS publications have illustrated the ability to use our depression definitions to predict other outcomes (31) or to relate individual factors to depression risk (42) . Although the outcome we used may capture both major and minor depressions, these different endpoints have equal health burden in older persons including medical costs or functional outcomes (43) and, thus, have public health importance. Although lack of diagnositic interview remains a limitation, we observe consistent findings in multiple sensitivity analyses applying alternate outcome definitions. Second, because all exposures were self-reported from the questionniares, misclassification is unevitable. However, many have been validated in the NHS (16) (17) (18) (19) (20) ; for example, self-reported and measured weights were highly correlated (γ = 0.97). Third, although sleep difficulty was significantly associated with high LLD risk in both 2-and 6-year lagged analyses, reverse causation cannot be completely ruled out if sleep disturbance manifests very early in the process. Fourth, PAF estimates assume causal links, which cannot be tested in observational studies including our study. However, a long-term randomizaed trial has inherent challenges; for example, the necessity of a large sample size, lengthy follow-up, participant adherence to assigned lifestyle prescriptions are difficult to achieve. Furthermore, the assignment to specific health conditions has ethnic problems to implement. Therefore, carefully-conducted observational studies provide a reasonable approach for evaluating the study aims. We also estimated the PAF from multivariable-adjusted models to minimize confounding; yet, residual confounding remained likely. Furthermore, we had to dichotomize exposures to increase interpretability and statistical efficiency in PAF analyses, although many showed strong dose-response relations. Finally, our findings from this all-female cohort may not be directly generalizable to men. Further research directly conducted in men and diverse race/ ethnic groups would be valuable.
In conclusion, we identified several major risk factors in the social, lifestyle/behavioral and health/medical domains with trend effects. Together, model predictors accounted for almost 60% of all new LLD cases in this population, and physical/functional limitation is the largest single contributor to total risk. A substantial proportion of LLD cases may be preventable by increasing exercise and intervening or preventing sleep difficulties and pain. These results may translate to public health opportunities in reducing depression burden.
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